BioCentury
ARTICLE | Company News

Molecular Targeting Technologies, University of Notre Dame deal

March 8, 2010 8:00 AM UTC

Molecular Targeting received an exclusive, worldwide license to the university's phosphatidylserine targeting molecule and related technology. The molecule, which selectively targets dead and dying m...